A 68-Year-Old Man with Covid-19 and Acute Kidney Injury – Case Records of the Massachusetts General Hospital
The case report discusses the difficulties in the treatment of this patient with acute kidney disease. Acute kidney injury —
Tag: Covid-19
Nanotechnology-based antiviral therapeutics
Nanotechnology has emerged as one of the most promising technologies on account of its ability to deal with viral diseases
Antiviral Viroblock masks modified by CD from Wacker
Innovation in Textiles reported on the new masks of Swiss textile innovator HeiQ. The new mask, HeiQ Viroblock NPJ03 was
The Lord of the NanoRings: cyclodextrins and the battle against SARSCoV-2
Making a comparison between CDs and the unique Ring of the legendary novel of The Lord of the Rings, J.
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Veklury® (Remdesivir) for the Treatment of COVID-19
Gilead Sciences, Inc. announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration
New coronavirus appears to be several-decade-old….. in Bats
Scientists, Maciej Boni and colleagues at Pensylvania State University’s Center for Infectious Disease Dynamics, published in Nature Microbiology that the
European Commission secures EU access to Remdesivir for treatment of COVID-19
The European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand
Nobel Prize-Winning Scientist Explains Why New Study in New England Journal of Medicine May Point To Nitric Oxide as Successful Treatment For COVID-19
Cision PR Newswire has published the news from Louis Ignarro awarded the Nobel Prize in Physiology or Medicine for his
Clinical trial: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses
Given the current lack of effective COVID-19 treatment, it is necessary to explore alternative methods to contain the spread of
Two coronavirus vaccines show immune response in human trials
Advanced Science News published on the results of clinical trials of two vaccines against SARS-CoV-2. Three months ago, the University of